Benchling — Startup Profile
Unified R&D Cloud for life sciences
HQ: San Francisco, California, US | Founded: 2012 | Employees: 1,000-1,500 (estimated: true, as of late 2024) | Stage: Late Stage VC | Website: https://www.benchling.com
About
Benchling provides a unified R&D Cloud platform with core products spanning Bioresearch, Bioprocess, Connect, Invivo, Insights, and Pipebio, designed to manage research data and workflows in molecular biology and related life sciences disciplines. The platform supports the development of emerging modalities such as RNA-based treatments, serving as a centralized collaboration and data management layer for biotech and pharmaceutical R&D teams. Its architecture targets regulated environments where data integrity, audit trails, and cross-functional collaboration are operational necessities.
The Take
Benchling operates a unified cloud platform that manages research data, workflows, and collaboration for life sciences R&D, embedding itself into regulated biotech processes where switching costs are high.
Key Metrics
- Latest Valuation: $6.1B
- Last Round: Late Stage, Nov 2021
- Total Funding: At least $21.5M disclosed
- Headcount: Unknown
- Founded: 2012
- Est. Runway: 39 months
Funding Rounds
- Round: $7M (2016-10-03) — Thrive Capital
- Round: $14.5M (2018-06-14) — Benchmark Capital
- Round: Undisclosed (2021-11-18) — Altimeter Capital Management, Franklin Templeton
Key People
- Saji Wickramasekara
- Ashu Singhal
- Saji Wickramasekara
- Ashu Singhal
- Ciarán O'Rourke
Key Competitors
- Dotmatics —
- LabVantage —
- Google (Google Health / Google Cloud for Life Sciences) —
Timeline Highlights
- 2021-11-18: Late Stage Funding at $6.1B Valuation
- 2018-06-14: Series B
- 2016-10-03: Growth Funding
- 2012: Company Founded
Recent News
- Biotech platform Benchling valued at $6.1 billion in new funding (2021-11-18)
- Benchling raises $14.5M to help streamline collaboration among scientists (2018-06-14)
- Benchling launches unified platform supporting RNA-based treatments (2021)
Similar Startups
- Solugen — Bio-based chemical manufacturing via a modular enzymatic platform
- Altos Labs — Cellular rejuvenation programming to reverse disease and transform medicine
- Vilya — Computational biotech platform designing novel molecular structures to target disease biology
- Colossal Biosciences — De-extinction and genetic engineering company resurrecting extinct species
- eGenesis — Genome engineering for human-compatible organ transplants
More Biotech & Life Sciences Startups
- Solugen — Bio-based chemical manufacturing via a modular enzymatic platform
- Aether Biomachines — Designing industrial proteins with computers and biology.
- Enveda Biosciences — Finding medicines in the chemistry of nature.
Category: Biotech & Life Sciences Startups
Browse: Home | Blog | About | All Startups A-Z | Biotech & Life Sciences Startups | View full profile on StartupWiki